# A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin

> **NCT05151653** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 139 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 765250
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05151653
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-26
- **Primary completion:** 2024-09-13
- **Final completion:** 2024-09-13
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05151653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05151653, "A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05151653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*